Soligenix
SNGX
#10265
Rank
ยฃ9.92 M
Marketcap
ยฃ0.98
Share price
-3.62%
Change (1 day)
-56.46%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -ยฃ9.46 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ6.92 Million a decrease over its 2023 earnings that were of -ยฃ5.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ9.46 Million36.73%
2024 -ยฃ6.92 Million22.96%
2023 -ยฃ5.63 Million-45.74%
2022 -ยฃ10.37 Million11.88%
2021 -ยฃ9.27 Million-32.37%
2020 -ยฃ13.7 Million83.18%
2019 -ยฃ7.48 Million11.57%
2018 -ยฃ6.71 Million19.29%
2017 -ยฃ5.62 Million33%
2016 -ยฃ4.23 Million-19.7%
2015 -ยฃ5.26 Million5.16%
2014 -ยฃ5.01 Million
2010 -ยฃ5.65 Million26.12%
2009 -ยฃ4.48 Million75.1%
2008 -ยฃ2.56 Million-45.38%
2007 -ยฃ4.69 Million-22.84%
2006 -ยฃ6.07 Million66.15%
2005 -ยฃ3.66 Million-16.65%
2004 -ยฃ4.38 Million13.28%
2003 -ยฃ3.87 Million-11.88%
2002 -ยฃ4.39 Million-59.44%
2001 -ยฃ10.82 Million378.18%
2000 -ยฃ2.27 Million-38.53%
1999 -ยฃ3.69 Million-18.43%
1998 -ยฃ4.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cleveland BioLabs
CBLI
-ยฃ2.04 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.73 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ8.76 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ23.96 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ30.9 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.43 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.31 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel